Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPRC5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AKR1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC220077 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HOOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LAMA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930476 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130872 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506844 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX4IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on